|
Market Closed -
Nasdaq
16:00:00 2025-04-01 EDT
|
5-day change | 1st Jan Change | ||
| 131.87 USD | -0.04% |
|
-.--% | - |
| 25-04-15 | J&J Boosts Outlook Despite Incoming Tariff Costs -- Update | DJ |
| 25-04-15 | J&J Increases Outlook After Beating 1Q Expectations | DJ |
Upcoming events on Intra-Cellular Therapies, Inc.
No events available
Past events on Intra-Cellular Therapies, Inc.
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 250 249 0.38% | 464 468 -0.81% | 681 675 0.87% |
|
EBITDA Million USD | Released Forecast Spread | -263 -276 4.73% | -159 -173 8.37% | -116 -109 -7.04% |
|
EBIT Million USD | Released Forecast Spread | -264 -274 3.7% | -159 -172 7.53% | -117 -109 -7.03% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -256 -271 5.52% | -139 -154 9.86% | -74,2 -73,5 -0.99% |
|
Net income Million USD | Released Forecast Spread | -256 -270 5.14% | -140 -155 10.02% | -74,7 -72,5 -3.03% |
|
EPS USD | Released Forecast Spread | -2,72 -2,87 5.09% | -1,46 -1,63 10.25% | -0,72 -0,72 -0.5% |
| Announcement Date | 01/03/23 | 22/02/24 | 21/02/25 |
Quarterly results
| Fiscal Period | December | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 111 107 3.72% | 126 119 5.83% | 132 136 -2.63% | 145 141 2.42% | 161 158 2.22% | 175 172 1.75% | 199 193 3.07% |
|
EBITDA Million USD | Released Forecast Spread | -47,1 -57,2 17.75% | -29,6 -65,1 54.53% | -34,0 -50,7 32.99% | -20,8 -35,5 41.35% | -27,6 -28,1 1.8% | -38,7 -29,3 -32.12% | -29,1 -22,4 -29.86% |
|
EBIT Million USD | Released Forecast Spread | -47,2 -57,8 18.39% | -29,7 -58,1 48.89% | -34,1 -47,4 28.04% | -21,0 -34,2 38.67% | -27,7 -25,0 -10.8% | -38,8 -29,4 -32.31% | -29,2 -22,0 -32.66% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -42,6 -55,5 23.16% | -24,2 -55,5 56.38% | -28,1 -42,1 33.19% | -14,9 -30,1 50.53% | -16,2 -22,3 27.48% | -26,0 -21,0 -23.42% | -17,2 -13,1 -31.71% |
|
Net income Million USD | Released Forecast Spread | -42,8 -56,5 24.3% | -24,3 -56,5 57.04% | -28,6 -42,5 32.68% | -15,2 -31,7 51.88% | -16,2 -21,3 23.81% | -26,3 -20,5 -28.53% | -16,9 -9,83 -71.73% |
|
EPS USD | Released Forecast Spread | -0,45 -0,59 23.89% | -0,25 -0,59 57.32% | -0,30 -0,45 33.67% | -0,16 -0,33 51.02% | -0,16 -0,21 24.17% | -0,25 -0,21 -19.59% | -0,16 -0,12 -35.11% |
| Announcement Date | 03/08/23 | 02/11/23 | 22/02/24 | 07/05/24 | 07/08/24 | 30/10/24 | 21/02/25 |
| 2026-09-03 |  | Earnings presentation | 02:00 |
| 2026-09-03 | | Earnings presentation | 03:00 |
| 2026-09-06 | | Extraordinary General Meeting | 22:00 |
| 2026-09-08 | | Extraordinary General Meeting | 02:30 |
| 2026-09-09 | | Ex-dividend date - 1.62 AUD | 00:00 |
| 2026-09-09 | | Extraordinary General Meeting | 03:00 |
| 2026-09-10 | | Extraordinary General Meeting | 02:30 |
| 2026-09-10 | | Extraordinary General Meeting | 02:00 |
| 2026-09-28 | | Extraordinary General Meeting | 02:30 |
| 2026-09-28 | | Extraordinary General Meeting | 01:30 |
Past sector events for Intra-Cellular Therapies, Inc.
| 2026-09-01 | | Earnings presentation | 04:00 |
| 2026-08-31 | | Extraordinary General Meeting | 02:00 |
| 2026-08-31 | | Earnings release - Q2 2026 | |
| 2026-08-30 | | Earnings presentation | 23:00 |
| 2026-08-30 | | Earnings presentation | 21:30 |
| 2026-08-30 | | Board of Directors Meeting | |
| 2026-08-30 | | Earnings release - Q2 2026 | |
| 2026-08-30 | | Earnings release - Q2 2026 | |
| 2026-08-30 | | Board of Directors Meeting | |
| 2026-08-29 | | Earnings release - Q2 2026 |
- Stock Market
- Stocks
- ITCI Stock
- Calendar Intra-Cellular Therapies, Inc.
Select your edition
All financial news and data tailored to specific country editions
